WO2009041787A3 - Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease - Google Patents
Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease Download PDFInfo
- Publication number
- WO2009041787A3 WO2009041787A3 PCT/KR2008/005723 KR2008005723W WO2009041787A3 WO 2009041787 A3 WO2009041787 A3 WO 2009041787A3 KR 2008005723 W KR2008005723 W KR 2008005723W WO 2009041787 A3 WO2009041787 A3 WO 2009041787A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- piper nigrum
- inhibitors
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Piper nigrum extract having prophylactic and therapeutic effects on inflammatory or infectious diseases, and to amide compounds isolated therefrom. In addition, the present invention relates to a pharmaceutical composition for preventing or treating inflammatory or infectious diseases, comprising the Piper nigrum extract or amide compound isolated therefrom as an active ingredient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070097968A KR100954866B1 (en) | 2007-09-28 | 2007-09-28 | Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from Piper nigrum for the prevention and treatment of inflammatory disease |
KR10-2007-0097968 | 2007-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009041787A2 WO2009041787A2 (en) | 2009-04-02 |
WO2009041787A3 true WO2009041787A3 (en) | 2009-05-14 |
Family
ID=40512030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2008/005723 WO2009041787A2 (en) | 2007-09-28 | 2008-09-26 | Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100954866B1 (en) |
WO (1) | WO2009041787A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010136221A1 (en) * | 2009-05-29 | 2010-12-02 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics |
FR2957259B1 (en) * | 2010-03-12 | 2012-04-27 | Silab Sa | ACTIVE REFINING COSMETIC PRINCIPLE FROM PIPER NIGRUM, COSMETIC COMPOSITIONS INCLUDING THE SAME AND USE THEREOF |
WO2012091685A1 (en) * | 2010-12-30 | 2012-07-05 | Anandechakunkorn Siridechpong | Thai herb modified traditional drugs |
CA2738357C (en) * | 2011-04-07 | 2019-08-06 | Amerisciences, Lp | Methods and compositions to promote ocular health |
KR20140057040A (en) * | 2012-11-02 | 2014-05-12 | 연세대학교 산학협력단 | Compositions for improving skin aging comprising piperine compounds as active ingredients |
KR101431987B1 (en) * | 2013-09-12 | 2014-08-22 | 중앙대학교 산학협력단 | Composition for treating contact dermatitis comprising pellitorine as an active ingredient |
CN104587070A (en) * | 2015-02-25 | 2015-05-06 | 胡运冲 | Traditional Chinese medicine composition for treating wind-cold-dampness arthralgia and stasis type cervical spondylosis |
KR20200078803A (en) | 2018-12-21 | 2020-07-02 | 강릉원주대학교산학협력단 | An anti-inflammatory or immunological enhancing composition comprising a Halocynthia aurantium tunic lipids as an active ingredient |
CZ309814B6 (en) * | 2022-01-04 | 2023-11-01 | Ústav experimentální botaniky AV ČR, v. v. i | Phenylpropanoid derivatives, preparations containing these derivatives and their use |
CN115636801B (en) * | 2022-10-26 | 2024-01-09 | 武汉润禾生物医药有限公司 | Amide alkaloid and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005298429A (en) * | 2004-04-14 | 2005-10-27 | Maruzen Pharmaceut Co Ltd | Vascular endothelial type nitric oxide synthase activity promoter |
US7081260B2 (en) * | 2002-10-29 | 2006-07-25 | Council Of Scientific And Industrial Research | α-Glucosidase inhibitors from a natural source |
-
2007
- 2007-09-28 KR KR1020070097968A patent/KR100954866B1/en active IP Right Grant
-
2008
- 2008-09-26 WO PCT/KR2008/005723 patent/WO2009041787A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7081260B2 (en) * | 2002-10-29 | 2006-07-25 | Council Of Scientific And Industrial Research | α-Glucosidase inhibitors from a natural source |
JP2005298429A (en) * | 2004-04-14 | 2005-10-27 | Maruzen Pharmaceut Co Ltd | Vascular endothelial type nitric oxide synthase activity promoter |
Non-Patent Citations (3)
Title |
---|
ASHOK K ET AL.: "Investigation toward new lead compounds from medicinally important plants", PURE APPL. CHEM., vol. 77, no. 1, 2005, pages 25 - 40 * |
JOCHEN R ET AL.: "Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro", J. ETHNOPHARMACOL., vol. 75, 2001, pages 133 - 139 * |
SARVESH KUMAR ET AL.: "Piperine inhibits TNF- a induced adhesion of neutrophils to endothelial monolayer through suppression of NF- K B and I K B kinase activation", EUR. J. PHARMACOL., vol. 575, August 2007 (2007-08-01), pages 177 - 186 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009041787A2 (en) | 2009-04-02 |
KR100954866B1 (en) | 2010-04-28 |
KR20090032601A (en) | 2009-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009041787A3 (en) | Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease | |
WO2007096151A3 (en) | Inhibitors of p38-kinase for treatment of pulmonary hypertension | |
WO2007133637A3 (en) | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same | |
WO2009144555A8 (en) | Pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2004078712A3 (en) | Isoquinoline derivatives and methods of use thereof | |
WO2008070129A3 (en) | Compositions and methods for the treatment of inflammatory disease | |
WO2007019251A3 (en) | Sphingosine kinase inhibitors and methods of their use | |
WO2007109192A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2011058474A8 (en) | N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
WO2007109172A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2008022256A3 (en) | Methods and compositions for preventing or treating age-related diseases | |
EA200900613A1 (en) | SPIROKETONE ACETYL-COA-CARBOXYLAS INHIBITORS | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
WO2007109154A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2009030952A3 (en) | Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway | |
WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
WO2007109182A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
WO2006093832A3 (en) | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same | |
WO2007123939A8 (en) | Novel arylamino n-heteraryls as mek inhibitors | |
WO2007028022A3 (en) | Novel compounds as p2x7 modulators and uses thereof | |
WO2007109201A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08834301 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08834301 Country of ref document: EP Kind code of ref document: A2 |